Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00488722
Status:
UNKNOWN
Last Update Posted:
2007-06-26
First Post:
2007-06-19
Brief Title:
A Prospective Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 36mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive Premenopausal Operable Breast Cancer
Sponsor:
Tianjin Medical University
Organization:
Tianjin Medical University
Organization Data
Organization:
Tianjin Medical University
Class:
OTHER
Study ID:
jzhang
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tianjin Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None